Location · Salt Lake City, UT
Clinical trials in Salt Lake City, UT
319 recruiting studies have a site in the Salt Lake City area, and 97 of them accept healthy volunteers. The area includes West Valley City, Murray, Sandy, South Jordan, West Jordan, Draper and nearby cities.
319 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- Recruiting
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
SPIRE Therapeutics Inc.
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Anniston, AL + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Cullinan Therapeutics Inc.
- Location
- Orlando, FL + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Chiesi Farmaceutici S.p.A.
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Tucson, AZ + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
X4 Pharmaceuticals
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Gilbert, AZ + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- La Jolla, CA + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Birmingham, AL + 20 other US sites
- Eligibility basics
- Ages 18–64
- Recruiting
FORWARD CAD IDE Study
Shockwave Medical, Inc.
- Location
- La Jolla, CA + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
PPD Development, LP
- Location
- Fresno, CA + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
PPD Development, LP
- Location
- Fresno, CA + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
PPD Development, LP
- Location
- Fresno, CA + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
PPD Development, LP
- Location
- Fresno, CA + 26 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W.L.Gore & Associates
- Location
- La Jolla, CA + 30 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2/Phase 3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Kyverna Therapeutics
- Location
- Los Angeles, CA + 9 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder
Cognitive FX
- Location
- Provo, UT
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
AbbVie
- Location
- Anaheim, CA + 30 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Chandler, AZ + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- San Francisco, CA + 3 other US sites
- Eligibility basics
- Ages 2–11
- Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Edwards Lifesciences
- Location
- Birmingham, AL + 20 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Novartis Pharmaceuticals
- Location
- Los Angeles, CA + 21 other US sites
- Eligibility basics
- Ages 12–60
- RecruitingPhase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
- Location
- Birmingham, AL + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of CRD-4730 in CPVT
Cardurion Pharmaceuticals, Inc.
- Location
- San Francisco, CA + 4 other US sites
- Eligibility basics
- Ages 18–99